A detailed history of Spire Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Spire Wealth Management holds 19,852 shares of BMY stock, worth $803,013. This represents 0.04% of its overall portfolio holdings.

Number of Shares
19,852
Previous 17,409 14.03%
Holding current value
$803,013
Previous $893,000 20.49%
% of portfolio
0.04%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$47.98 - $54.4 $117,215 - $132,899
2,443 Added 14.03%
19,852 $1.08 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $84,985 - $101,411
-1,753 Reduced 9.15%
17,409 $893,000
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $170,370 - $190,500
-2,943 Reduced 13.31%
19,162 $1.11 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $207,121 - $229,975
-3,251 Reduced 12.82%
22,105 $1.41 Million
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $597,435 - $677,626
9,092 Added 55.9%
25,356 $1.76 Million
Q4 2022

Feb 03, 2023

BUY
$68.48 - $81.09 $44,922 - $53,195
656 Added 4.2%
16,264 $1.17 Million
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $1,534 - $906,712
-11,800 Reduced 43.05%
15,608 $1.11 Million
Q2 2022

Jul 22, 2022

BUY
$72.62 - $79.98 $72,402 - $79,740
997 Added 3.77%
27,408 $2.11 Million
Q1 2022

Apr 18, 2022

SELL
$61.48 - $73.72 $1.94 Million - $2.32 Million
-31,537 Reduced 54.42%
26,411 $1.93 Million
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $1.49 Million - $1.74 Million
27,771 Added 92.03%
57,948 $3.61 Million
Q3 2021

Oct 22, 2021

BUY
$59.17 - $69.31 $102,304 - $119,836
1,729 Added 6.08%
30,177 $1.79 Million
Q2 2021

Jul 26, 2021

SELL
$61.91 - $67.42 $2.47 Million - $2.69 Million
-39,941 Reduced 58.4%
28,448 $1.9 Million
Q1 2021

May 21, 2021

BUY
$59.34 - $66.74 $4.06 Million - $4.56 Million
68,389 New
68,389 $3.64 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.